Suggestions
Ashoka Madduri
Business Development at Strand Therapeutics I Biotech Corporate Strategy & BD I MIT MBA
Dr. Ashoka Madduri, a highly accomplished professional with a diverse educational background and extensive experience in the fields of biochemistry, chemistry, and business administration.
He holds a Ph.D. in Bioorganic Chemistry from the University of Groningen, an MBA from the MIT Sloan School of Management, and has pursued postdoctoral research at prestigious institutions such as Harvard University and TU Dortmund University.
Dr. Madduri has held various key positions in renowned organizations, including Sr Director of Business Development at Strand Therapeutics, where he played a vital role in driving strategic initiatives and fostering partnerships.
His career journey includes roles such as Strategy Consultant at Aviceda Therapeutics, Director of Strategy & Partnerships at Wave Life Sciences, and Vice President of Innovation at Integrity Bio-Chem.
With a solid foundation in academia and a proven track record in corporate environments, Dr. Madduri brings a wealth of expertise in areas such as molecularly imprinted polymers (MIPs), research and development, strategic planning, and business development.
His contributions to the field have been substantial, evident from his roles as a research fellow at institutions like Brigham and Women's Hospital and Syngenta.
As a former Research Associate at TU Dortmund University and a Director/Head of R&D at HPPE LLC, Dr. Madduri has demonstrated his proficiency in leading scientific endeavors and driving innovation.
Moreover, his involvement in academia, coupled with his industry experience, reflects a holistic approach towards problem-solving and fostering growth opportunities in the biotechnology and life sciences sectors.
Dr. Ashoka Madduri's career trajectory showcases a blend of scientific acumen, managerial skills, and strategic vision, making him a valuable asset in the realm of biopharmaceuticals and corporate strategy.
His transition from impactful roles at Aviceda Therapeutics to Wave Life Sciences and his tenure as an Executive MBA candidate at MIT Sloan School of Management underscore his commitment to continuous learning and professional growth.
